Michael O. Sullivan
2021
In 2021, Michael O. Sullivan earned a total compensation of $682.4K as Chief Financial Officer at Oragenics, a 28% increase compared to previous year.
Compensation breakdown
| Bonus | $70,000 |
|---|---|
| Option Awards | $367,000 |
| Salary | $238,304 |
| Other | $7,124 |
| Total | $682,428 |
Sullivan received $367K in option awards, accounting for 54% of the total pay in 2021.
Sullivan also received $70K in bonus, $238.3K in salary and $7.1K in other compensation.
Rankings
In 2021, Michael O. Sullivan's compensation ranked 9,976th out of 12,405 executives tracked by ExecPay. In other words, Sullivan earned more than 19.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,976 out of 12,405 | 20th |
Division Manufacturing | 4,410 out of 5,494 | 20th |
Major group Chemicals And Allied Products | 1,960 out of 2,369 | 17th |
Industry group Drugs | 1,740 out of 2,090 | 17th |
Industry Pharmaceutical Preparations | 1,293 out of 1,537 | 16th |
Source: SEC filing on October 30, 2023.
Sullivan's colleagues
We found one more compensation record of an executive who worked with Michael O. Sullivan at Oragenics in 2021.
2021
Martin Handfield
Oragenics